| 标题 |
Efficacy and Safety of Firsekibart in Patients With Acute Gout Unsuitable for Standard Therapy: 48-Weeks Results From an Open-Label Extension of a Randomized Phase 3 Trial
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Zhu Z, Xue Y, Chu T,et al. Efficacy and Safety of Firsekibart in Patients With Acute Gout Unsuitable for Standard Therapy: 48-Weeks Results From an Open-Label Extension of a Randomized Phase 3 Trial. Advances in therapy.2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
Criminology34
Kao
OK
小小牛马
有人
cdercder
张欢馨
GingerF
Essence
乐空思
炜大的我
东方元语
ming2026
lucky
sanvva
luang
一介书生
赵赶超
dde
皖公网安备34019202002308
